A New Way to Characterize Proteins is Here!

RedShift BioAnalytics has developed a game changing analytical technique called Microfluidic Modulation Spectroscopy, or MMS, that combines mid-infrared laser spectroscopy, microfluidics and signal processing to create a powerful new methodology for directly probing the biophysical structure of proteins. This new generation bioanalytical tool has the capability to measure stability, similarity, concentration, secondary structure and aggregation in a single automated analysis.

From Discovery to Manufacturing

With a measurement capability from 0.1 mg/ml to 200 mg/ml our system is a simple to use, bench top analyzer for the rapid characterization of therapeutic proteins from discovery to manufacturing. Its speed and flexibility are ideal for use in:

  • Screening for lead candidate selection
  • Preformulation and formulation development
  • Process development optimization
  • Measuring and predicting stability
  • Routine analytics, process monitoring, and QC release

Request an application note

Click on this text to email request to RedshiftBio for an application note on our technology, entitled Microfluidic Modulation Spectroscopy (MMS) For Protein Therapeutic Drug Analysis.